Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III

Blood

Volumn 97, Issue 4, 2001, Pages 1079-1085

  Dunzendorfer, S ^a   Kaneider, N ^a   Rabensteiner, A ^a   Meierhofer, C ^a   Reinisch, C ^a   Romisch J ^a   Wiedermann, C J ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; ANTITHROMBIN III CONCENTRATE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; PHOSPHODIESTERASE; PROTEIN KINASE C; PROTEOHEPARAN SULFATE; SYNDECAN; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; HUMAN; HUMAN CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0035865626     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.4.1079     Document Type: Article

References (46)

1. Neutrophil adhesion and the therapy of inflammation
2. The role of antithrombin III in severe sepsis-anticoagulation and beyond
3. Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation
4. Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways
5. Neutrophil-induced liver injury in endotoxin shock is a CD11b/CD18 dependent mechanism
6. Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome
7. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis
8. Antithrombin: Facts and new hypotheses
9. Influence of antithrombin III on coagulation and inflammation in porcine septic shock
10. Reduction of mortality with antithrombin III in septicemic rats: A study of Klebsiella pneumoniae-induced sepsis
11. Efficacy of antithrombin III in endotoxin-induced disseminated intravasal coagulation
12. Synergistic protection from lung damage by combining antithrombin III and α1-proteinase inhibitor on the E. coli endotoxemic sheep pulmonary dysfunction model
13. Antithrombin III in patients with severe sepsis: A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
14. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion
15. Antithrombin III deficiency primes the endothelial inflammatory response via up-regulation of adhesion molecules
16. Antithrombin III inhibits T and B lymphocyte activation in vitro and improves parameters of inflammation in a rat model of acute lung allograft rejection
17. Leukocyte chemoattractant peptides from the serpin heparin cofactor II
18. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
19. Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro
20. Antithrombin-heparin cofactor
21. Characterization of interleukin-8 receptors in human neutrophil membranes: Regulation by guanine nucleotides
22. Implications of the three-dimensional structure of α1-antitrypsin for structure and function of serpins
23. Biological implications of a 3 Å structure of dimeric antithrombin
24. The role of the COOH-terminal region of antithrombin III: Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor
25. Release of a two-chain form of antithrombin from the antithrombin-thrombin complex
26. Release of neutrophil elastase and its role in tissue injury in acute inflammation: Effect of the elastase inhibitor, FR 134043
27. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions; resolution of the anti-thrombin conformational change contribution to heparin rate enhancement
28. Structure and functional expression of a human interleukin-8 receptor
29. Cross-desensitization of receptors for peptide chemoattractants: Characterization of a new form of leukocyte regulation
30. CD45: An emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development
31. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis
32. CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes
33. Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase
34. Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes
35. Cross-competition for binding of alpha 1-antitrypsin (alpha 1 AT)-elastase complexes to the serpin-enzyme complex receptor by other serpin-enzyme complexes and by proteolytically modified alpha 1 AT
36. Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor
37. In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P
38. Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells
39. Sequence identity between the alpha 2-macroglobulin receptor and low-density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor
40. Syndecans: Multifunctional cell-surface co-receptors
41. Biosynthesis of heparin and related polysaccharides
42. Heparin-like glycosaminoglycans is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells
43. Heparan sulfates as membrane receptors for the fibroblast growth factors
44. Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C
45. Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase C alpha
46. Chemoattractant receptor cross-talk as a regulatory mechanism in leukocyte adhesion and migration